Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease
Avik Majumdar, Emmanuel Tsochatzis
Metabolism (2020) Vol. 111, pp. 154291-154291
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review
Luca Rinaldi, Pia Clara Pafundi, Raffaele Galiero, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 270-270
Open Access | Times Cited: 135
Reactive Oxygen Species Induce Fatty Liver and Ischemia-Reperfusion Injury by Promoting Inflammation and Cell Death
Shen-ping Tang, Xin‐Li Mao, Yahong Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 97
What Is New in Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals: From Bench to Bedside
Pojsakorn Danpanichkul, Kanokphong Suparan, Donghee Kim, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 1, pp. 278-278
Open Access | Times Cited: 21
Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD)
Stergios A. Pοlyzos, Christos S. Mantzoros
Metabolism (2020) Vol. 111, pp. 154318-154318
Open Access | Times Cited: 42
Pure total flavonoids from citrus alleviate oxidative stress and inflammation in nonalcoholic fatty liver disease by regulating the miR-137-3p/NOXA2/NOX2 pathway
Junbin Yan, Yunmeng Nie, Sumei Xu, et al.
Phytomedicine (2023) Vol. 118, pp. 154944-154944
Closed Access | Times Cited: 15
Metabolic associated fatty liver disease: Addressing a new era in liver transplantation
Madeleine Gill, Avik Majumdar
World Journal of Hepatology (2020) Vol. 12, Iss. 12, pp. 1168-1181
Open Access | Times Cited: 38
Non-alcoholic fatty liver disease: Current therapeutic options
Avik Majumdar, Jef Verbeek, Emmanuel Tsochatzis
Current Opinion in Pharmacology (2021) Vol. 61, pp. 98-105
Open Access | Times Cited: 23
Emerging Drug Therapies for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Glimpse into the Horizon
Jorge Arnold, Francisco Idalsoaga, Luis Antonio Díaz, et al.
Current Hepatology Reports (2024) Vol. 23, Iss. 1, pp. 204-219
Closed Access | Times Cited: 3
Natural Products in the Modulation of Farnesoid X Receptor Against Nonalcoholic Fatty Liver Disease
Jing Wang, Na Yang, Yu Xu
The American Journal of Chinese Medicine (2024) Vol. 52, Iss. 02, pp. 291-314
Closed Access | Times Cited: 3
MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis
Jiaofeng Huang, Wenjuan Xue, Ming-Fang Wang, et al.
Diabetes Metabolic Syndrome and Obesity (2021) Vol. Volume 14, pp. 3417-3425
Open Access | Times Cited: 19
Profiling of cell‐free DNA methylation and histone signatures in pediatric NAFLD: A pilot study
Diana Búzová, Maria Rita Braghini, Salvatore Daniele Bianco, et al.
Hepatology Communications (2022) Vol. 6, Iss. 12, pp. 3311-3323
Open Access | Times Cited: 12
Maladaptive regeneration and metabolic dysfunction associated steatotic liver disease: Common mechanisms and potential therapeutic targets
Dandan Wu, Stan F.J. van de Graaf
Biochemical Pharmacology (2024) Vol. 227, pp. 116437-116437
Open Access | Times Cited: 2
Characterization of hepatic fatty acids using magnetic resonance spectroscopy for the assessment of treatment response to metformin in an eNOS−/− mouse model of metabolic nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Begoña Lavin, Thomas R. Eykyn, Alkystis Phinikaridou, et al.
NMR in Biomedicine (2023) Vol. 36, Iss. 8
Open Access | Times Cited: 6
Approach to the Patient With Nonalcoholic Fatty Liver Disease
Renata Belfort‐DeAguiar, Romina Lomonaco, Kenneth Cusi
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 108, Iss. 2, pp. 483-495
Closed Access | Times Cited: 9
Metabolic puzzle: Exploring liver fibrosis differences in Asian metabolic-associated fatty liver disease subtypes
Sabhita Shabir Shaikh, Fakhar Ali Qazi Arisar, Saba Nafay, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 1, pp. 54-64
Open Access | Times Cited: 1
Current status of liver transplantation for non‐B non‐C liver cirrhosis and hepatocellular carcinoma
Takahiro Nishio, Takashi Ito, Koichiro Hata, et al.
Annals of Gastroenterological Surgery (2022) Vol. 7, Iss. 1, pp. 42-52
Open Access | Times Cited: 4
Hígado graso (parte 1): aspectos generales, epidemiología, fisiopatología e historia natural
Jhon Edison Prieto Ortíz, Carlos Bernardo Sánchez Luque, Rolando José Ortega Quiróz
Revista Colombiana de Gastroenterología (2022) Vol. 37, Iss. 4, pp. 420-433
Open Access | Times Cited: 4
Nonalcoholic Fatty Liver Disease Incidence and Remission and Their Predictors During 7 Years of Follow-up Among Finns
Satu Korpimäki, Suvi Rovio, Markus Juonala, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 1, pp. e291-e305
Open Access | Times Cited: 2
Associations of advanced liver fibrosis with heart failure with preserved ejection fraction in type 2 diabetic patients according to obesity and metabolic goal achievement status
Wangyan Jiang, Zhelong Liu, Shaohua Liu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 2
Non-alcoholic Fatty Liver Disease Is Associated With Aortic Calcification: A Cohort Study With Propensity Score Matching
Rongrong Zhu, Xuping Gao, Minqi Liao, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 3
The Hidden Epidemic: The Prevalence and Impact of Concurrent Liver Diseases in Patients Undergoing Liver Transplantation in Australia and New Zealand
Jess Howell, Avik Majumdar, Michael Fink, et al.
Transplantation Direct (2022) Vol. 8, Iss. 8, pp. e1345-e1345
Open Access | Times Cited: 3
The prevalence of disorders of the gut-brain axis in type 2 diabetes mellitus patients with metabolic dysfunction-associated fatty liver disease: an observational study
Thomas Van Nieuwenhove, Gertjan Rasschaert, Antje V. Kharagjitsingh, et al.
Acta Gastro Enterologica Belgica (2021) Vol. 84, Iss. 4, pp. 541-547
Open Access | Times Cited: 4
Multifactorial Aspects of Adiponectin in Non- Alcoholic Fatty Liver Disease
Aswathi Rajan, L Karpagavel, Midhun TM, et al.
Journal Of Advanced Zoology (2023) Vol. 44, Iss. 3, pp. 903-930
Open Access
Referral to hepatologists or a second-line examination requirement is common in patients with type 2 diabetes mellitus
Wangyan Jiang, Yongli Yan, Gang Yuan, et al.
Nutrition Metabolism and Cardiovascular Diseases (2023) Vol. 34, Iss. 5, pp. 1314-1324
Closed Access
Development of a multivariable prediction model of functional exercise capacity in liver transplant recipients
Maria Goreti Angelino Willuweit, Agnaldo José Lopes, Arthur de Sá Ferreira
Journal of Liver Transplantation (2021) Vol. 6, pp. 100067-100067
Open Access
Page 1 - Next Page

Scroll to top